|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
9,000,000 |
Market
Cap: |
1.80(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.15 - $0.94 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Histogen is a biotechnology company focusing on the development and commercialization of medicines to treat chronic diseases.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Spada Alfred P. |
See RemarksOfficer |
|
2023-02-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,235 |
|
-28% |
|
Spada Alfred P. |
See RemarksOfficer |
|
2023-02-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
979 |
|
-28% |
|
Pascoe Richard W |
President, CEO & Director |
|
2021-03-30 |
4 |
B |
$1.14 |
$22,800 |
D/D |
20,000 |
30,000 |
2.81 |
- |
|
Pascoe Richard W |
President, CEO & Director |
|
2020-12-03 |
4 |
B |
$1.24 |
$12,394 |
D/D |
10,000 |
10,000 |
2.81 |
- |
|
Jackson Jonathan |
Director |
|
2020-05-26 |
4 |
A |
$0.00 |
$0 |
I/I |
2,356,597 |
2,356,597 |
|
- |
|
Latterich Martin |
See Remarks |
|
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
11,951 |
11,951 |
|
- |
|
Chang Stephen |
Director |
|
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
14,485 |
14,485 |
|
- |
|
Satz Brian |
Director |
|
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,434 |
1,434 |
|
- |
|
Naughton Gail K |
See Remarks |
|
2020-05-26 |
4 |
A |
$0.00 |
$0 |
I/I |
426,526 |
426,526 |
|
- |
|
Zhang Yizhuo |
Director |
|
2020-05-26 |
4 |
A |
$0.00 |
$0 |
I/I |
600,983 |
600,983 |
|
- |
|
Mento Steven J |
Director |
|
2020-05-22 |
4 |
D |
$0.56 |
$17,600 |
D/D |
(31,428) |
39,572 |
|
- |
|
Mento Steven J |
Director |
|
2020-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
65,000 |
71,000 |
|
- |
|
Marshall Keith W |
EVP, COO & CFO |
|
2020-05-22 |
4 |
D |
$0.56 |
$10,424 |
D/D |
(18,615) |
19,885 |
|
- |
|
Marshall Keith W |
EVP, COO & CFO |
|
2020-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
38,500 |
38,500 |
|
- |
|
Spada Alfred P. |
EVP, R&D and CSO |
|
2020-05-22 |
4 |
D |
$0.56 |
$7,258 |
D/D |
(12,960) |
19,595 |
|
- |
|
Spada Alfred P. |
EVP, R&D and CSO |
|
2020-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,343 |
32,555 |
|
- |
|
Smith Edward F Iii |
SVP, Reg Affairs and QA |
|
2018-11-14 |
4 |
A |
$3.15 |
$5,431 |
D/D |
1,724 |
10,875 |
|
- |
|
Ripley Daniel L. |
SVP, Bus Dev, P&A Mgmt |
|
2018-11-14 |
4 |
A |
$3.15 |
$5,862 |
I/I |
1,861 |
32,431 |
|
- |
|
Smith Edward F Iii |
SVP, Reg Affairs and QA |
|
2018-05-14 |
4 |
A |
$3.31 |
$15,524 |
D/D |
4,690 |
9,151 |
|
- |
|
Ripley Daniel L. |
SVP, Bus Dev, P&A Mgmt |
|
2018-05-14 |
4 |
A |
$3.31 |
$4,270 |
I/I |
1,290 |
30,570 |
|
- |
|
Mento Steven J |
President, CEO & Director |
|
2018-05-04 |
4 |
OE |
$0.99 |
$59,400 |
D/D |
60,000 |
60,000 |
|
- |
|
Spada Alfred P. |
EVP, R&D and CSO |
|
2018-02-27 |
4 |
OE |
$1.24 |
$15,030 |
D/D |
12,121 |
12,121 |
|
- |
|
Smith Edward F Iii |
SVP, Reg Affairs and QA |
|
2017-11-14 |
4 |
A |
$3.48 |
$15,524 |
D/D |
4,461 |
4,461 |
|
- |
|
Ripley Daniel L. |
SVP, Bus Dev, P&A Mgmt |
|
2017-11-14 |
4 |
A |
$3.48 |
$2,847 |
I/I |
818 |
29,280 |
|
- |
|
Ripley Daniel L. |
SVP, Bus Dev, P&A Mgmt |
|
2017-05-12 |
4 |
A |
$1.70 |
$1,294 |
I/I |
761 |
28,462 |
|
- |
|
99 Records found
|
|
Page 1 of 4 |
|
|